A004 – Neurosciences

Research objectives

The main objective of the Neuroscience Area is to search for new therapeutic targets and improve the clinical-therapeutic management of neurological patients, mainly stroke, Alzheimer’s disease, Parkinson’s disease, headaches and neurological prion diseases.

  • Identification and validation of diagnostic and therapeutic targets in neurological diseases
  • Treatment of neurological diseases caused by prions
  • Study and treatment of nervous system tumors
  • The creation and application of new drugs
  • Cell and gene therapy
  • Study of the cellular and molecular mechanisms involved in neurological diseases
  • Nanomedicine applied to Neurosciences
  • Promotion and development of clinical trials in early phases
  • Development of clinical practice guidelines in neurological diseases

Research groups

Area coordinator

José Luis Labandeira García

José Luis Labandeira García

Area subcoordinator

A004 subcoordinador – Francisco Campos

Francisco Campos Pérez

El Dr. Francisco Campos hizo su formación postdoctoral en IIBB-CSIC (Barcelona) (2007-08), en el Instituto de Investigaciones Sanitarias de Santiago de Compostela (IDIS) (2009-10) y Massachusetts General Hospital-Harvard Medical School (2011-12). Desde 2013 es investigador Miguel Servet. Es autor d